Cargando…
Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy
Melittin, the principal constituent in bee venom, is an attractive candidate for cancer therapy. However, its clinical applications are limited by hemolysis, nonspecific cytotoxicity, and rapid metabolism. Herein, a novel genetically engineered vesicular antibody‐melittin (VAM) drug delivery platfor...
Autores principales: | Zhang, Jianzhong, Liu, Xue, Xia, Yutian, Xu, Shuyu, Liu, Xuan, Xiao, Haiqing, Wang, Xiaoyong, Liu, Chao, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658496/ https://www.ncbi.nlm.nih.gov/pubmed/38023709 http://dx.doi.org/10.1002/btm2.10482 |
Ejemplares similares
-
Leveraging Multimodal Deep Learning Architecture with Retina Lesion Information to Detect Diabetic Retinopathy
por: Tseng, Vincent S., et al.
Publicado: (2020) -
Trifluoroacetic acid as excipient destabilizes melittin causing the selective aggregation of melittin within the centrin-melittin-trifluoroacetic acid complexa)
por: Pastrana-Rios, Belinda, et al.
Publicado: (2015) -
Melittin-Based Nano-Delivery Systems for Cancer Therapy
por: Wang, Anqi, et al.
Publicado: (2022) -
EXTRACELLULAR VESICLES AS REGULATORS OF IMMUNE FUNCTION IN TRAUMATIC INJURIES AND SEPSIS
por: Seim, Roland F., et al.
Publicado: (2023) -
THE ROLES OF EXTRACELLULAR VESICLES IN SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
por: Weber, Birte, et al.
Publicado: (2023)